Epigenetic regulation of the miR142-3p/interleukin-6 circuit in glioblastoma.

[1]  H. Colman,et al.  Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation , 2013, Oncogene.

[2]  D. Nam,et al.  Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. , 2013, Cancer cell.

[3]  B. Kristensen,et al.  MicroRNA biomarkers in glioblastoma , 2013, Journal of Neuro-Oncology.

[4]  A E Giuliano,et al.  Assessment of DNA methylation status in early stages of breast cancer development , 2013, British Journal of Cancer.

[5]  Hiroya Tamaki,et al.  PU.1-Dependent Transcriptional Regulation of miR-142 Contributes to Its Hematopoietic Cell–Specific Expression and Modulation of IL-6 , 2013, The Journal of Immunology.

[6]  H. H. Andersen,et al.  A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion , 2012, Molecular Neurobiology.

[7]  M. Wicha,et al.  Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. , 2012, Molecular cell.

[8]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[9]  Jia Yu,et al.  MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. , 2012, Blood.

[10]  Salil Sharma,et al.  Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy , 2012, EMBO molecular medicine.

[11]  Weilin Wu,et al.  IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. , 2012, Molecular cell.

[12]  A. Viale,et al.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012, Nature.

[13]  Yang-Hsin Shih,et al.  Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. , 2012, Biomaterials.

[14]  H. Guan,et al.  Sp1 is upregulated in human glioma, promotes MMP‐2‐mediated cell invasion and predicts poor clinical outcome , 2012, International journal of cancer.

[15]  S. Varambally,et al.  Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. , 2011, Blood.

[16]  Min Liu,et al.  MicroRNA‐142‐3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells , 2011, FEBS letters.

[17]  Yoshitaka Narita,et al.  Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. , 2010, Genes & development.

[18]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[19]  P. Cartron,et al.  Dnmt1/Transcription factor interactions: an alternative mechanism of DNA methylation inheritance. , 2010, Genes & cancer.

[20]  T. Smyrk,et al.  Upregulation of DNA Methyltransferase–Mediated Gene Silencing, Anchorage-Independent Growth, and Migration of Colon Cancer Cells by Interleukin-6 , 2010, Molecular Cancer Research.

[21]  T. Patel,et al.  MicroRNA‐dependent regulation of DNA methyltransferase‐1 and tumor suppressor gene expression by interleukin‐6 in human malignant cholangiocytes , 2010, Hepatology.

[22]  Paul A. Khavari,et al.  DNMT1 Maintains Progenitor Function in Self-Renewing Somatic Tissue , 2010, Nature.

[23]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[24]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[25]  P. Cappabianca,et al.  HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. , 2009, Cancer research.

[26]  Paolo Malatesta,et al.  SOX2 Silencing in Glioblastoma Tumor‐Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity , 2009, Stem cells.

[27]  S. Vandenberg,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. , 2008 .

[28]  T. Patel,et al.  Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes , 2008, Oncogene.

[29]  K. Mitsuya,et al.  The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA , 2007, Nature.

[30]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[31]  S. Jacobsen,et al.  UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells , 2007, Science.

[32]  Mark R Gilbert,et al.  Chemoradiotherapy in malignant glioma: standard of care and future directions. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  I. Lorimer,et al.  Regulation of p27Kip1 by miRNA 221/222 in Glioblastoma , 2007, Cell cycle.

[34]  S. Pradhan,et al.  Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells* , 2007, Journal of Biological Chemistry.

[35]  G. Petsko.  Transformation , 2006, Genome Biology.

[36]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[37]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[38]  S. Pradhan,et al.  Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Aguzzi,et al.  IL-6 is required for glioma development in a mouse model , 2004, Oncogene.

[40]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[41]  Yusuke Yamamoto,et al.  Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  G. Deng,et al.  CCAAT-Binding Factor Interfering with the Binding of Transcription Factor Causing Changes in Chromatin Conformation and Gene Expression by APC Promoter Methylation Inhibits , 2004 .